When was Remedee Labs founded?

Remedee Labs was founded in 2016.

Where is Remedee Labs located?

Remedee Labs is headquartered in Meylan, France.

How many employees does Remedee Labs have?

As of Aug 31, 2026, the latest employee count at Remedee Labs is 29.

Is Remedee Labs a funded company?

Remedee Labs is a funded company, having raised a total of $27.8M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round.

When was the latest funding round of Remedee Labs?

Remedee Labs' latest funding was a $***** Series A round on Dec 06, 2022, with participation from 4 investors.

Where does Remedee Labs rank among its competitors?

Remedee Labs ranks 3rd amongst 61 active competitors, of which 7 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was SPR, which secured $5.99M in Mar, 2025.

Who are the top competitors of Remedee Labs?

Remedee Labs' top competitors include SPR, PainChek and Sure Med Compliance. Among them, SPR secured the most recent funding round in March, 2025.

Remedee Labs - 2026 Company Profile, Funding & Competitors

Remedee Labs is a series A company based in Meylan (France), founded in 2016. It operates as a Developer of endorphin stimulation therapy for pain management. Remedee Labs has raised $27.8M in funding from investors like HCVC, Generali and Bpifrance. The company has 61 active competitors, including 7 funded and 5 that have exited. Its top competitors include companies like SPR, PainChek and Sure Med Compliance.

Company Details

Developer of endorphin stimulation therapy for pain management The platform has developed endorphin stimulation therapy using patented Microelectronic Endorphin Trigger (MEET) technology. Multiple clinical trials are ongoing for therapies such as innocuity, arthrosis, surgical pain, and migraine among others.

Website: remedeelabs.com
Social
Email ID: *****@remedee.com

Key Metrics

Founded Year

2016

Location

Meylan, France

Stage

Series A

Total Funding

$27.8M in 4 rounds

Latest Funding Round

Series A, Dec 06, 2022, $*****

Investors

HCVC & 8 more

Ranked

3^rd among 61 active competitors

Employee Count

29 as on Aug 31, 2026

Similar Companies

SPR & 88 more

View Remedee Labs' full profile

Remedee Labs has raised a total funding of $27.8M over 4 rounds. Its latest funding round was a Series A round on Dec 06, 2022 for $*****. 4 investors participated in its latest round. Remedee Labs has 9 institutional investors.

Here is the list of recent funding rounds of Remedee Labs:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 06, 2022	2061858	Series A	5206860	2602754	3195705	8308648
Apr 2019	9377387	Series A	8352514	4323141	1119017	PAR Technology Corp & 3 more
2016	9673	Seed	7519	3474	4238	4422

Access funding benchmarks and valuations. Sign up today!

View details of Remedee Labs's funding rounds and investors

Remedee Labs' employee count trend

Remedee Labs has 29 employees as of Aug 26. Here is Remedee Labs's employee count trend over the years:

Uncover Remedee Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Remedee Labs include SPR, PainChek and Sure Med Compliance. Here is the list of Top 10 competitors of Remedee Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SPR 2008, Cleveland (United States), Acquired	Developer of non-implant peripheral nerve stimulation systems for pain management	$132M	Revelation Partners, RC Capital & 13 others	55/100
2nd	PainChek 2010, Sydney (Australia), Public	Provider of pain assessment and monitoring app	-	Gwentrpb	45/100
3rd	Remedee Labs 2016, Meylan (France), Series A	Developer of endorphin stimulation therapy for pain management	$27.8M	C4 Ventures, Generali & 7 others	43/100
4th	Sure Med Compliance 2015, Mobile (United States), Seed	Provider of a digital health platform for pain management	$1M	ProAssurance, Innovate Alabama	42/100
5th	NeuraLace Medical 2016, San Diego (United States), Seed	Non-invasive neuromodulation for chronic neuropathic pain relief and improved patient outcomes	$5.85M	FusionX Ventures, BioBrit & 7 others	40/100
6th	Neurometrix 1996, Woburn (United States), Acquired	Developer of non-invasive medical devices for pain and neurological disorders	$14.6M	Deerfield, MIT & 8 others	38/100
7th	Electromedical Technologies 2007, Phoenix (United States), Public	An electrotherapy device that helps reduce and eliminate chronic or acute pain	$105K	Yorkville Advisors	38/100
8th	iTENS 1999, Akron (United States), Unfunded	Wireless pain relief device merging technology with TENS therapy	-	-	38/100
9th	PainQx 2014, New York City (United States), Seed	AI based pain measurement platform for human and veterinary care providers	$2.71M	SBIR, Arizona Tech Investors & 11 others	37/100
10th	Hollywog 2009, Chattanooga (United States), Unfunded	Pain relief solutions: TENS units, gel pads, and accessories	-	-	37/100